Figures
Abstract
Peritonitis is the leading complication of peritoneal dialysis, which is primarily caused by bacteria rather than fungi. Peritonitis is responsible for approximately 18% of the infection-related mortality in peritoneal dialysis patients. In this paper, we report the isolation of a rare fungus, Quambalaria cyanescens, from the peritoneal fluid of a man after he switched from continuous ambulatory peritoneal dialysis to nocturnal intermittent peritoneal dialysis. Based on the morphological examination and multigene phylogeny, the clinical isolate was confirmed as Q. cyanescens. This pathogen exhibited low sensitivity to all tested echinocandins and 5-flucytosine. Interestingly, morphological characterization revealed that Q. cyanescens UM 1095 produced different pigments at low temperatures (25°C and 30°C) on various culture media. It is important to monitor the emergence of this rare fungus as a potential human pathogen in the tropics. This study provides insight into Q. cyanescens UM 1095 phenotype profiles using a Biolog phenotypic microarray (PM). Of the 760 nutrient sources tested, Q. cyanescens UM 1095 utilized 42 compounds, and the fungus can adapt to a broad range of osmotic and acidic environments. To our knowledge, this is the first report of the isolation of Q. cyanescens from peritoneal fluid, revealing this rare fungus as a potential human pathogen that may be misidentified using conventional methods. The detailed morphological, molecular and phenotypic characterization of Q. cyanescens UM 1095 provides the basis for future studies on its biology, lifestyle, and potential pathogenicity.
Citation: Kuan CS, Yew SM, Toh YF, Chan CL, Lim SK, Lee KW, et al. (2015) Identification and Characterization of a Rare Fungus, Quambalaria cyanescens, Isolated from the Peritoneal Fluid of a Patient after Nocturnal Intermittent Peritoneal Dialysis. PLoS ONE 10(12): e0145932. https://doi.org/10.1371/journal.pone.0145932
Editor: Abelardo I. Aguilera, Hospital Universitario de La Princesa, SPAIN
Received: September 4, 2015; Accepted: December 10, 2015; Published: December 30, 2015
Copyright: © 2015 Kuan et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Data Availability: The ITS, SSU and D1/D2 domain nucleotide sequences of Q. cyanescens UM 1095 are available from the GenBank with accession numbers KT186106, KT186108 and KT186107, respectively.
Funding: This study was supported by High Impact Research MoE Grant UM.C/625/1/HIR/MOHE/MED/31 (Account no. H-20001-00-E000070) from the Ministry of Education Malaysia. Codon Genomics SB provided support in the form of salaries for authors KWL, CCH and WYY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.
Competing interests: Authors KWL, CCH and WYY are employed by Codon Genomics SB. The other authors named in the manuscript are from University of Malaya. All other authors have declared that no competing interests exist. These affiliations do not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
Introduction
Quambalariaceae is a new family of fungi belonging to the order Microstromatales in the class Exobasidiomycetes [1]. The family comprises the single genus Quambalaria. de Beer et al. [1] first described the taxonomic changes in plant pathogenic species in the genera Ramularia and Sporothrix to propose a new genus, Quambalaria, to accommodate Ramularia pitereka and Sporothrix eucalypti. The first Q. cyanescens isolate (strain CBS 357.73) was recovered from human skin and described as Sporothrix cyanescens in 1973 [2]. In 1987, Moore et al. [3] showed that the cells of this fungus contain dolipore septa and coenzyme Q-10 and thus reassigned the fungus into a new basidiomycetes genus (Cerinosterus cyanescens). Based on a molecular analysis of partial large subunit (LSU)-rDNA, a later study revealed that C. cyanescens was closely related to Microstroma juglandis but differed from other species within the genus Cerinosterus [4]. Sigler et al. [4] then established the new genus Fugomyces and renamed C. cyanescens as Fugomyces cyanescens. The phylogenetic analysis of the internal transcribed spacer (ITS) region in conjunction with the LSU sequences and ultrastructural analysis data reclassified Fugomyces cyanescens in the new family Quambalariaceae as Q. cyanescens [1]. The analysis also confirmed that Q. pitereka, Q. eucalypti and Q. cyanescens are distinct species [1]. To date, the fungal genus Quambalaria contains five species, including Q. cyanescens, Q. pitereka, Q eucalypti, Q. coyrecup and Q. simpsonii [1,5–7].
Q. cyanescens is a hyaline basidiomycete isolated from a broad range of ecological niches, including air, soil, and insect larvae as well as in association with diverse plant sources in various countries [1,2,6,8]. Q. cyanescens is frequently associated with bark beetles feeding on numerous plants [9]. This fungus, however, is predominantly known as non-pathogenic to plants and has been reported as a symbiont of plants, including Corymbia and Eucalyptus species [1,6]. Notably, Q. cyanescens produces the antibiotic sesquiterpene globulol [10]. The crude extract isolated from colored-pigmented endophytic Quambalaria species (closely related to Q. cyanescens) exhibited potent antimicrobial activities against various human and plant pathogens [11,12]. Stodulkova et al. [13] described a novel active metabolite naphthoquinone (quambalarine A) with broad antifungal and antibacterial activity from Q. cyanescens.
Q. cyanescens is a rare human basidiomycetous pathogen [4,14,15]. The accumulation of data from reported clinical cases suggest that this species is potentially an opportunistic pathogen isolated primarily from immunocompromised or debilitated individuals [4,15]. Q. cyanescens was also reported as an environmental contaminant associated with pseudoepidemic nosocomial pneumonia [14], and this rare fungus was recently recovered from a female patient after augmentation mammoplasty [16].
We report the first case of Q. cyanescens isolated from the peritoneal fluid of a patient after nocturnal intermittent peritoneal dialysis. The characteristic morphological features and molecular data identified the fungal strain as Q. cyanescens UM 1095. The present study provides insight into Q. cyanescens UM 1095 phenotype profiles, including its nutrient utilization pattern and sensitivity to osmolytes, ions and acidic environments, using the Phenotypic MicroArray (PM) system.
Materials and Methods
Ethic statement
Approval for this study was obtained from the Medical Ethics Committee of the University Malaya Medical Centre (reference number: 20157–1519), and written consent was obtained (S1 Fig).
Clinical history
A 49-year-old male was found to have end-stage renal disease (ESRD) due to hypertensive nephrosclerosis and admitted to the nephrology ward of the Division of Nephrology of UMMC for hemodialysis in April 2014. On 8 December 2014, the patient received continuous ambulatory peritoneal dialysis (CAPD) after Tenckhoff catheter insertion on 21 November 2014. He was recruited to an Automated Peritoneal Dialysis (APD) trial. His APD regime was a two-hour cycle for five cycles per night, using two bags of 5 L 2.5% dialysate. He was stable on CAPD treatment until he changed to nocturnal intermittent peritoneal dialysis (NIPD) treatment using automated cycler machine on 19 December 2014. During NIPD treatment, cloudy peritoneal effluence was observed, but the patient had no symptoms and signs of peritoneal irritation, including fever, abdominal pain, diarrhea or vomiting. He was treated empirically as peritoneal peritonitis and was started on intra-peritoneal (IP) antibiotics, i.e. ceftazidime (IP, 1 g stat and 250 mg 6 hourly) and Cefazolin (IP, 1 g stat and 250 mg 6 hourly). Peritoneal fluid examination showed the presence of 560/μL neutrophils (95% polymorph) and confirmed the diagnosis of peritoneal peritonitis. He demonstrated initial response with reducing peritoneal fluid white cell count from 560/μL to 240/μL. Nonetheless, the peritoneal fluid culture revealed the growth of yeast-like organism and the patient started to receive antifungal therapy (IV fluconazole). He denied any contact with animals and had no recent travel. His Tenckhoff catheter was subsequently removed on 14 January 2015 due to the unresolved peritonitis. He completed 14 days of IV fluconazole and was discharged well. He received CAPD treatment two months after the resolution of peritonitis.
Fungal isolate
Q. cyanescens UM 1095 was isolated from the peritoneal dialysis fluid of a dialysis patient with suspected peritonitis after switching from continuous ambulatory peritoneal dialysis to nocturnal intermittent peritoneal dialysis in the Division of Nephrology, University Malaya Medical Centre (UMMC), Kuala Lumpur, Malaysia. The morphological and cultural features of Q. cyanescens UM 1095 were examined on Sabouraud dextrose agar (SDA), potato dextrose agar (PDA), corn meal agar (CMA) and V8 agar incubated at 25°C, 30°C and 35°C for three days, with alternate-day examination for fungal growth. The macroscopic examination was performed to study the colonial characteristics, including the color of the pigment, texture, and topography. A slide culture was carried out as previously described with slight modifications [17]. The slide cultures were performed by growing the fungus on SDA, PDA, CMA and V8 agar; the slides were examined after 3-day incubation to observe the microscopic structure of the fungus species.
In vitro antifungal susceptibility
The in vitro antifungal susceptibility of Q. cyanescens UM 1095 was examined using the Sensititre YeastOne (TREK Diagnostic System, Cleveland, OH, USA) with a broth microdilution method according to the Clinical and Laboratory Standards Institute (CLSI) M38-A2 guidelines. The isolate was tested against nine antifungal agents (fluconazole, itraconazole, posaconazole, voriconazole, anidulafungin, caspofungin, micafungin, 5-flucytosine and amphotericin B), and the minimum inhibitory concentrations (MICs) were examined after 24-hour incubation.
DNA sequencing and multilocus phylogenetic analysis
The internal transcribed spacer region (ITS), the small subunit of the ribosomal RNA gene (SSU) and the D1/D2 domain of the 26S rRNA gene were used as targets for the molecular identification of the fungal isolate. Total DNA extraction, PCR amplification, and sequencing were performed as described previously [14,15]. The primers used are listed in S1 Table. The annealing temperatures used to amplify the ITS, SSU and D1/D2 domain of the 26S rDNA genes were 58°C, 52°C and 56°C, respectively. The sequenced data (ITS, SSU, and D1/D2 sequences) were subjected to a BLASTn search against the non-redundant (nr) NCBI-nucleotide database for species identification. Unique ITS and D1/D2 nucleotide sequences from the isolate, together with an additional 14 sequences for the ITS region and D1/D2 domain, respectively, of the Quambalaria species were compiled for multilocus phylogenetic analysis (Table 1). Microstroma juglandis was used as an outgroup strain in the phylogenetic analysis. Multiple sequence alignments of collected ITS and D1/D2 nucleotide sequences were generated using M-Coffee [18]. Individual alignments were concatenated for Bayesian Markov Chain Monte Carlo (MCMC) analysis partitioned by the gene. Bayesian tree analyses were performed using MrBayes v3.2.2 with reversible jump MCMC averaging over the entire general time reversible (GTR) rates and gamma-distributed rate heterogeneity for all subsets of the partitioned scheme. A total of 1,000,000 generations were run with a sampling frequency of 100, and diagnostics were calculated for every 1,000 generations. The first 2,500 trees were discarded with a burn-in setting of 25%. Convergence was assessed with a standard deviation of split frequencies below 0.01, no noticeable trend for the plot of the generation versus the log probability of the data, and a potential scale reduction factor (PSRF) close to 1.0 for all parameters.
Phenotype microarray experiments
The metabolic profile of Q. cyanescens UM 1095 was evaluated using Biolog PM analysis (Biolog Inc., Hayward, CA, USA). Ten MicroPlate panels (PM1 to PM10), which included carbon, nitrogen, phosphorus, sulfur, nutrient supplements, peptide nitrogen, osmolytes and pH sources, were used in this study. S2 Table summarizes the substrates used in the phenotype microarray experiments.
Q. cyanescens UM 1095 was grown on SDA at 35°C for 24 hours. The cell suspension was extracted by rolling a sterile, wetted cotton swab over the colonies and resuspended in 15 mL IFY-0 inoculating fluid (Biolog Inc., Hayward, CA, USA). The uniform cell suspension was adjusted to 62% transmission at OD590 nm using a turbidimeter (Biolog Inc., Hayward, CA, USA).
PM1-10 inoculating fluids were prepared according to the manufacturer’s protocol (S3 Table). PM1-10 inoculum suspensions along with different inoculating fluids were prepared as shown in S4 Table. All the wells of PM1-10 were inoculated with 100 μL of the prepared inoculum suspensions and incubated in the Omnilog machine at 35°C for 96 hours. The first well with water was used as a negative control. The experiment was performed in duplicate. The data for each assay from the duplicates were averaged to obtain a mean of the replicates. Based on the 96-hour reading, the heat maps were constructed using Omnilog values ≥150,000.
Results
Colonial morphology of Q. cyanescens UM 1095 on agar
The Q. cyanescens UM 1095 white colonies on SDA were sparse at 25°C but became dense at 30°C and 35°C (Fig 1A). The strain grew more slowly at 25°C and tended to be yeast-like with moist and smooth colonies. At 30°C, the colonies were dried, coarse, and irregular with an umbonate elevation and undulate margin (Fig 1A). At 35°C, the colonies were dried, circular with convex elevation and had an undulate margin. Red pigments were observed diffusing into the agar within 48 hours at 25°C and 30°C on SDA. The production of red pigments was more visible at lower temperatures (25°C and 30°C) than at 35°C (Fig 1A). The diameters of the colonies ranged from 0.05 cm to 0.1 cm, 0.02 cm to 0.3 cm and 0.1 cm to 0.2 cm after 3-day incubation at 25°C, 30°C and 35°C, respectively. Overall, the UM 1095 clinical isolate was found to be morphologically related to Q. cyanescens based on these characteristics [16].
The surface and close-up view of the colonial morphology of Q. cyanescens UM 1095 after being cultured for four days on (A) SDA, (B) PDA, (C) V8 agar and (D) CMA at 25°C, 30°C and 35°C.
The Q. cyanescens UM 1095 isolate grew well on PDA, V8, and CMA at 25°C, 30°C and 35°C. Dark brown and purple pigments were observed diffusing into agar within 48 hours at 25°C and 30°C on PDA and V8, respectively (Fig 1B and 1C). However, no pigment was produced when the fungus was cultured on CMA (Fig 1D). On PDA, yeast-like colonies with butyrous and filiform margins accompanied by a dark brown pigment were observed at 25°C (Fig 1B). At 30°C and 35°C, dense and white circular colonies with an umbonate elevation and filiform margin were observed (Fig 1B). The diameters of colonies ranged from 0.2 cm to 0.3 cm, 0.1 cm to 0.4 cm and 0.05 cm to 0.35 cm after 3-day incubation on PDA at 25°C, 30°C and 35°C, respectively. On V8 agar, yeast-like purple and circular colonies with an umbonate elevation and filiform margin were observed at 25°C and 30°C (Fig 1C). At 35°C, white, circular and creamy colonies with convex elevation and an entire margin were observed (Fig 1C). The diameters of colonies ranged from 0.2 cm to 0.3 cm, 0.05 cm to 0.3 cm, 0.05 cm to 0.18 cm after 3-day incubation at 25°C, 30°C and 35°C, respectively. The Q. cyanescens UM 1095 colonies on CMA were small, sparse with an umbonate elevation and filiform margin at 25°C, 30°C and 35°C (Fig 1D). The colonial diameters ranged from 0.1 cm to 0.2 cm, 0.003 cm to 0.3 cm, 0.005 cm to 0.2 cm after 3-day incubation on CMA at 25°C, 30°C and 35°C, respectively.
Microscopic examination of Q. cyanescens UM 1095
A distinct yeast form of Q. cyanescens UM 1095 was observed on SDA, PDA, and CMA. Microscopic examination showed a pseudohyphal budding pattern, and the yeast-like cells (1–5 × 1–2 μm) were ovoid, ellipsoid or cylindrical shape with a sympodial conidiogenesis (Fig 2A, 2B and 2D). The filamentous form of Q. cyanescens UM 1095 was clearly observable on V8 agar, which demonstrated branched and suberected hyphae (Fig 2C). Microscopically, a repeated proliferation of conidiogenous cells was frequently observed. The primary conidia arose by the sympodial growth of the conidiogenous cells and carried several secondary conidia (Fig 2C). In addition, chlamydospores were identified in a culture growing on V8 agar (Fig 2C). No chlamydospores were observed in a culture growing on SDA, CMA, PDA, and V8 agar.
Light micrograph showing the micromorphology of Q. cyanescens UM 1095 on (A) SDA, (B) PDA, (C) V8 agar and (D) CMA. The chlamydospore is indicated by an arrow (400× magnification, bars 20 μm).
Sequence-based identification and phylogenetic analysis
The preliminary morphological identification of the Q. cyanescens UM 1095 isolate was confirmed by PCR amplification of the ITS, D1/D2 domain, and SSU nucleotide sequences, which yielded specific amplification products of approximately 617 bp (ITS), 583 bp (D1/D2 domain) and 1010 bp (SSU), respectively (S2 Fig). By querying ITS and SSU nucleotide sequences against those deposited in the NCBI-nucleotide database, the sequenced ITS of Q. cyanescens UM 1095 was found to be 100% (617/617 bp) identical to the ITS of Q. cyanescens strain AUMC 6293 and the SSU was 100% (1010/1010 bp) identical to the SSU of Q. cyanescens strain CBS 876.73. However, the D1/D2 domain of Q. cyanescens UM 1095 was 99% (582/583 bp) identical to the D1/D2 domain of Q. simpsonii culture-collection CBS:124773.
The species-level identification of UM 1095 was further confirmed using multilocus phylogenetic analysis. The sequenced ITS and D1/D2 domain gene regions were used to construct a phylogram using combined gene analysis with an additional 14 ex-type strains of the Quambalaria species. The SSU region was excluded in the multilocus phylogenetic analysis due to the limited number of Quambalaria SSU sequences in the NCBI database. As shown in Fig 3, the five Quambalaria species are well separated. Multilocus phylogenetic analysis revealed that UM 1095 was clustered together with Q. cyanescens strain 11PU348 (Fig 3). Based on the multigene phylogeny, the UM 1095 isolate was confirmed as Q. cyanescens.
The tree was rooted with M. juglandis as an outgroup. The numbers on the nodes indicate Bayesian posterior probability based on 100 sampling frequencies for a total of 100,000 generations.
In vitro antifungal susceptibility
Q. cyanescens UM 1095 is resistant to 5-flucytosine (MIC > 64 μg/mL) and all tested echinocandins, including anidulafungin (MIC > 8 μg/mL), caspofungin (MIC > 8 μg/mL) and micafungin (MIC > 8 μg/mL). Q. cyanescens UM 1095 is most likely susceptible to amphotericin B (MIC = 1 μg/mL) and fluconazole (MIC = 0.5 μg/mL), itraconazole (MIC = 0.03 μg/mL) and posaconazole (MIC = 0.015 μg/mL).
Nutrient utilization profile of Q. cyanescens UM 1095
We performed in-depth investigations of Q. cyanescens UM 1095 nutritional phenotypic profiles using Biolog PM analysis. Biolog PM metabolic panels (PMs 1–8) contain approximately 200 assays of carbon source metabolism, 400 assays of nitrogen source metabolism, 100 assays of phosphorus and sulfur source metabolism, and 100 assays of biosynthetic pathways (S2 Table). Overall, we observed that nutrient utilization was generally slow over the 4-day incubation.
A total of 42 compounds was utilized by Q. cyanescens UM 1095 of the 760 nutrient sources tested (Fig 4). Of 190 carbon sources (PM1 and PM2) tested, 26 simple sugars and complex carbohydrates were utilized by Q. cyanescens UM 1095 (Fig 4A). Among the nitrogenous compounds (PM3), L-cysteine (PM3, A11), L-glutamic acid (PM3, A12), glycine-methionine (PM3, H11) and methionine-alanine (PM3, H12) were utilized by Q. cyanescens UM 1095 (Fig 4B). Furthermore, L-cysteinyl-glycine (PM4, F9), L-methionine (PM4, G7), and glycyl-L-methionine were the only organic phosphorus and sulfur sources utilized by the isolate (Fig 4C). However, no nutritional supplement was utilized by Q. cyanescens UM 1095. PM analyses revealed that Q. cyanescens UM 1095 utilized certain peptide nitrogen sources (Fig 4D).
(A) Carbon sources. (B) Nitrogen sources. (C) Phosphorus and sulfur sources. (D) Peptide nitrogen sources. Conditions with a final Omnilog unit (at 96 hours) ≥ 15,000 were incorporated into the heat maps. The growth of Q. cyanescens UM 1095 in a particular substrate over the 96-hour incubation is represented by a color range, as given in the scale bar at the bottom of the figure.
Chemical sensitivity profile of Q. cyanescens UM 1095
In this study, we found that Q. cyanescens UM 1095 can adapt to a wide range of osmotic and pH environments. The Biolog PM chemical sensitivity panels (PM9 and PM10) that were used in this study consisted of approximately 100 assays of ion effects and osmolarity, 100 assays of pH effects and pH control with deaminases and decarboxylases (S2 Table). Each chemical sensitivity assay included at least four increasing doses of the test chemical. For sensitivity to osmolytes, Q. cyanescens UM 1095 was found to be very sensitive to several sodium salts with detectable growth, including sodium formate (2–6%), sodium benzoate pH 5.2 (20–100 mM) and sodium nitrite (10–100 mM; Fig 5A). In addition, PM analysis revealed that 10 mM ammonium sulfate was toxic for Q. cyanescens UM 1095 (Fig 5A). However, Q. cyanescens UM 1095 was capable of growing in potassium salt concentrations of 3–6%. The fungus was also found to be able to grow in other osmolytes and ions such as sodium sulfate, ethylene glycol, sodium phosphate and sodium nitrate (Fig 5A). Moreover, the results showed that Q. cyanescens UM 1095 can grow in an acidic environment, with maximum growth between pH 4.5 and 7 (Fig 5B).
(A) Osmotic/ions effects. (B) pH effects. Conditions with a final Omnilog unit (at 96 hours) ≥ 15,000 were incorporated into the heat maps. The growth of Q. cyanescens UM 1095 in a particular substrate over the 96-hour incubation is represented by a color range, as given in the scale bar at the bottom of the figure.
Discussion
Peritonitis is the main complication of peritoneal dialysis and is mostly caused by bacterial pathogens. An estimated 18% of the infection-related mortality in peritoneal dialysis patients is attributed to peritonitis [19]. By comparison, fungi only account for 1% to 15% of peritonitis [11,20–22]. However, fungal peritoneal dialysis-associated infections are commonly caused by Candida species and are usually associated with significant morbidity and mortality [23,24]. Various molds and yeasts, such as Aspergillus sp., Penicillium sp., Paecilomyces sp., Trichosporon sp., Rhodotorula sp. and Cryptococcal sp., are occasionally reported [22,25–27]. Nevertheless, polymicrobial peritonitis that is caused by either fungi or bacteria is a predictor of a poor response to antibiotic therapy [12]. Peritoneal dialysis-associated infection is a common cause of patients discontinuing peritoneal dialysis and switching to hemodialysis [19]. Hamai et al. [28] reported that there is a risk of peritonitis introduced by contamination from domestic pets. The case study showed that a nocturnal intermittent peritoneal dialysis patient was infected with unusual bacterial pathogens, including Enterobacter agglomerans, Pasteurella multocida and alpha-streptococcus, most likely due to transmission from the patient’s domestic cats [28]. In the present study, we isolated a rare clinical basidiomycetous fungus, Q. cyanescens, from the peritoneal fluid of a patient who switched from continuous ambulatory peritoneal dialysis to nocturnal intermittent peritoneal dialysis. This fungus has been isolated from heart transplant patients [15], lymphoma patients [4] and augmentation mammoplasty patients [16]. However, no apparent clinical evidence of infection was shown in these studies. Jackson et al. [14] proposed that Q. cyanescens may be an environmental contaminant. In the present study, the Q. cyanescens UM 1095 may be as an emerging pathogen to cause real infection or foreign-body reaction but not an environmental contaminant because i.) the patient denied to be contacted with any animals ii.) no other bacteria or fungi were isolated from the Tenckhoff catheter tip, iii.) the white blood cell count in the cloudy peritoneal effluent of the patient was abnormally high, and iv.) no other organism was isolated from the peritoneal fluid. However, at this stage of knowledge, the pathogenic role of Q. cyanescens in peritonitis remains unknown, although it is a low-virulence human pathogen [4].
At the initial stage, we failed to identify Q. cyanescens UM 1095 based on basic microbiological examination. Gram staining showed no bacteria but only fungal elements. On Brilliance Candida agar, we obtained dark blue and yeast-like colonial morphology and identified the isolate as a Candida species, as in a previous study [16]. The API 20C Aux yeast identification system (bioMérieux, Hazelwood, MO, USA) misidentified the isolate as Rhodotorula mucilaginosa, which did not correspond to the culture characteristics. This failure of accurate identification of our isolate identity was most likely due to the absence of a Quambalaria species database in the identification system. When standard assimilation tests fail to determine the isolate identity, species-level identification was achieved through specific culture characteristics and molecular characterization. Subsequent colonial morphological examination and multilocus phylogenetic analysis identified the clinical isolate as Q. cyanescens. In contrast to a previous study [16], multilocus phylogeny using the combined ITS and D1/D2 sequences not only was able to distinguish the distinct five species within the Quambalaria genus but also clustered our isolate with Q. cyanescens.
The main aim of peritonitis treatment is to resolve inflammation by eradicating the causative pathogen(s). The early and rapid identification of causative pathogen(s) is important with the advent of clinical management to ensure good clinical outcomes and to reduce the unnecessary overuse of antimicrobial agents. In this study, we found that Q. cyanescens UM 1095 had the same resistance profile as Q. cyanescens 11PU348, which exhibited high MICs to three compounds of the echinocandin class of drugs and 5-flucytosine. Echinocandin resistance is considered rare, although a few studies have shown echinocandin resistance in Candida albicans, C. parapsilosis, C. tropicalis, C. guilliermondii and C. kefyr [29–31]. In the literature, echinocandin resistance in Candida species is associated with the mutations in two hot spot regions of FKS genes, which encode the major subunit of the 1,3-D-glucan synthase complex [32–35]. However, the molecular basis underlying echinocandin resistance in Q. cyanescens UM 1095 is unknown.
All microbial pathogens require a variety of nutrient sources, including carbon, nitrogen, phosphorus and sulfur, for growth and proliferation. Here, we performed comprehensive phenotypic characterization and metabolic profiling of this rare clinical isolate using Biolog PM to provide a better understanding of its nutritional requirements, which are likely needed for it to grow. A closer analysis of the Biolog data revealed that Q. cyanescens UM 1095 has a high capacity to utilize a number of simple sugars and complex carbohydrates such as pectin and glycerol. This high variability may explain why Q. cyanescens is the only species of the Quambalaria genus that is found in virtually all habitats, including plants, insects, and humans. However, we observed that Q. cyanescens UM 1095 utilizes a narrow spectrum of nitrogen, phosphorus, sulfur and peptide nitrogen sources. The most striking finding was the high metabolic versatility of Q. cyanescens UM 1095 to grow and adapt to a broad range of osmotic environments. This adaptability may be an important contributing factor to its pervasive ability to grow in diverse unfavorable environments. As previously noted [36], 3% NaCl is the optimal condition for the growth of Hortaea werneckii, a causative agent of tinea nigra. However, Kogej et al. [37] showed that 3% NaCl is a concentration that is toxic to Saccharomyces cerevisiae. In the present study, PM analysis showed that Q. cyanescens UM 1095 is capable of growing well in NaCl concentrations of 1–3%. The ability of Q. cyanescens UM 1095 to utilize various osmolytes showed that the fungus has a good osmoadaptation system to tolerate osmotic stress, which merits further study.
Conclusion
In this study, we isolated a rare clinical fungal pathogen: Q. cyanescens UM 1095. This is the first reported isolation of Q. cyanescens from peritoneal fluid. Based on the macroscopic examination on agar, we observed that the clinical isolate exhibits a mycelium-yeast dimorphism characteristic, which is typical of Q. cyanescens. Multilocus phylogenetic analysis revealed that Q. cyanescens UM 1095 is tightly clustered with the Q. cyanescens strain 11PU348, which was also isolated from humans. In this study, Biolog PM was used to characterize the phenotypic profile of Q. cyanescens UM 1095. Comprehensive phenotypic characterization and metabolic profiling of this rare species enable the design of interventions to prevent the proliferation of this potential pathogen. The Biolog PM may be a effective diagnostic tool, especially when combined with multilocus phylogenetic analysis. We hope that the in-depth analysis of the Q. cyanescens UM 1095 phenotypic profile will help to decipher its basic biology and provide a valuable platform for future fungal research.
Supporting Information
S1 Fig. Witten consent obtained from the patient in the study.
https://doi.org/10.1371/journal.pone.0145932.s001
(PDF)
S2 Fig. PCR amplification of Q. cyanescens UM 1095 ITS, D1/D2 domain and SSU nucleotide sequences.
M1: 100 bp ladder (i-DNA Biotechnology); M2: Lambda DNA/HindIII Marker (Fermentas).
https://doi.org/10.1371/journal.pone.0145932.s002
(TIF)
S1 Table. Primers used for PCR amplification.
https://doi.org/10.1371/journal.pone.0145932.s003
(XLSX)
S2 Table. The full list of substrates assayed in the PM experiments.
https://doi.org/10.1371/journal.pone.0145932.s004
(XLSX)
S3 Table. Final concentrations of ingredients in PM inoculating fluids.
https://doi.org/10.1371/journal.pone.0145932.s005
(XLSX)
S4 Table. Preparation of PM1-10 inoculum suspensions.
https://doi.org/10.1371/journal.pone.0145932.s006
(XLSX)
Author Contributions
Conceived and designed the experiments: CSK KPN. Performed the experiments: CSK SMY YFT CLC SLN. Analyzed the data: CSK KWL. Contributed reagents/materials/analysis tools: KWL CCH WYY SKL. Wrote the paper: CSK KPN SKL SMY. Involved in clinical management and provided clinical details: SKL.
References
- 1. de Beer ZW, Begerow D, Bauer R, Pegg GS, Crous PW, Wingfield MJ. Phylogeny of the Quambalariaceae fam. nov., including important Eucalyptus pathogens in South Africa and Australia. Stud Mycol. 2006;55: 289–298. pmid:18490987
- 2. de Hoog GS, de Vries GA. Two new species of Sporothrix and their relation to Blastobotrys nivea. Antonie Van Leeuwenhoek. 1973;39: 515–520. pmid:4543058
- 3. Moore RT. Micromorphology of yeasts and yeast-like fungi and its taxonomic implications. Stud Mycol. 1987;30: 203–226.
- 4. Sigler L, Harris JL, Dixon DM, Flis AL, Salkin IF, Kemna M, et al. Microbiology and potential virulence of Sporothrix cyanescens, a fungus rarely isolated from blood and skin. J Clin Microbiol. 1990;28: 1009–1015. pmid:2351719
- 5. Simpson JA. Quambalaria, a new genus of eucalypt pathogens. Australasian Mycologist. 2000;19: 57–62.
- 6. Paap T, Burgess TI, McComb JA, Shearer BL, St JHGE. Quambalaria species, including Q. coyrecup sp. nov., implicated in canker and shoot blight diseases causing decline of Corymbia species in the southwest of Western Australia. Mycol Res. 2008;112: 57–69. pmid:18222081
- 7. Cheewangkoon R, Groenewald JZ, Summerell BA, Hyde KD, To-Anun C, Crous PW. Myrtaceae, a cache of fungal biodiversity. Persoonia. 2009;23: 55–85. pmid:20198162
- 8. Antropova AB, Bilanenko EN, Mokeeva VL, Chekunova LN, Kachalkin AV, Shtaer OV, et al. [Report of Quambalaria cyanescens associated with birch]. Mikrobiologiia. 2014;83: 605–614. pmid:25844472
- 9. Kolařík M, Sláviková E, Pažoutová S. The taxonomic and ecological characterization of the clinically important heterobasiodiomycete Fugomyces cyanescens and its association with bark beetles. Czech Mycology. 2006;58: 81–98.
- 10. Stodulkova E, Sulc M, Cisarova I, Novak P, Kolarik M, Flieger M. Production of (+)-globulol needle crystals on the surface mycelium of Quambalaria cyanescens. Folia Microbiol (Praha). 2008;53: 15–22.
- 11. Amin RM, Strobel GA, Vishnevetsky M, Ren Y, Geary B. Biologically active endophytic Quambalaria sp. from Leptospermum junipae in Australia. Mycology. 2010;1: 67–74.
- 12. Padhi S, Tayung K. Antimicrobial activity and molecular characterization of an endophytic fungus, Quambalaria sp. isolated from Ipomoea carnea. Annals of Microbiology. 2013;63: 793–800.
- 13. Stodulkova E, Cisarova I, Kolarik M, Chudickova M, Novak P, Man P, et al. Biologically active metabolites produced by the basidiomycete quambalaria cyanescens. PLoS One. 2015;10: e0118913. pmid:25723150
- 14. Jackson L, Klotz SA, Normand RE. A pseudoepidemic of Sporothrix cyanescens pneumonia occurring during renovation of a bronchoscopy suite. J Med Vet Mycol. 1990;28: 455–459. pmid:2093118
- 15. Tambini R, Farina C, Fiocchi R, Dupont B, Gueho E, Delvecchio G, et al. Possible pathogenic role for Sporothrix cyanescens isolated from a lung lesion in a heart transplant patient. J Med Vet Mycol. 1996;34: 195–198. pmid:8803800
- 16. Fan X, Xiao M, Kong F, Kudinha T, Wang H, Xu YC. A rare fungal species, Quambalaria cyanescens, isolated from a patient after augmentation mammoplasty—environmental contaminant or pathogen? PLoS One. 2014;9: e106949. pmid:25330078
- 17. Yew SM, Chan CL, Lee KW, Na SL, Tan R, Hoh CC, et al. A five-year survey of dematiaceous fungi in a tropical hospital reveals potential opportunistic species. PLoS One. 2014;9: e104352. pmid:25098697
- 18. Moretti S, Armougom F, Wallace IM, Higgins DG, Jongeneel CV, Notredame C. The M-Coffee web server: a meta-method for computing multiple sequence alignments by combining alternative alignment methods. Nucleic Acids Res. 2007;35: W645–W648. pmid:17526519
- 19. Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A, et al. Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int. 2010;30: 393–423. pmid:20628102
- 20. Hau T. Bacteria, toxins, and the peritoneum. World J Surg. 1990;14: 167–175. pmid:2183479
- 21. Kerr CM, Perfect JR, Craven PC, Jorgensen JH, Drutz DJ, Shelburne JD, et al. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Ann Intern Med. 1983;99: 334–336. pmid:6351688
- 22. Prasad KN, Prasad N, Gupta A, Sharma RK, Verma AK, Ayyagari A. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: a single centre Indian experience. J Infect. 2004;48: 96–101. pmid:14667798
- 23. Islam S, Zaidi AK, Wilson J. Peritoneal infection with multiple species of Candida: a case report. Surg Infect (Larchmt). 2002;3: 35–37.
- 24. Kleinpeter MA. Successful treatment of Candida infections in peritoneal dialysis patients: case reports and review of the literature. Adv Perit Dial. 2004;20: 58–61. pmid:15384796
- 25. Wang AY, Yu AW, Li PK, Lam PK, Leung CB, Lai KN, et al. Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single center. Am J Kidney Dis. 2000;36: 1183–1192. pmid:11096043
- 26. Goldie SJ, Kiernan-Tridle L, Torres C, Gorban-Brennan N, Dunne D, Kliger AS, et al. Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes. Am J Kidney Dis. 1996;28: 86–91. pmid:8712227
- 27. Nagappan R, Collins JF, Lee WT. Fungal peritonitis in continuous ambulatory peritoneal dialysis—the Auckland experience. Am J Kidney Dis. 1992;20: 492–496. pmid:1442761
- 28. Hamai K, Imai H, Ohtani H, Komatsuda A, Kodama T, Wakui H, et al. Repeated cat-associated peritonitis in a patient on automated nocturnal intermittent peritoneal dialysis. Clin Exp Nephrol. 1999;1: 59–61.
- 29. Axner-Elings M, Botero-Kleiven S, Jensen RH, Arendrup MC. Echinocandin susceptibility testing of Candida isolates collected during a 1-year period in Sweden. J Clin Microbiol. 2011;49: 2516–2521. pmid:21543574
- 30. Fekkar A, Meyer I, Brossas JY, Dannaoui E, Palous M, Uzunov M, et al. Rapid emergence of echinocandin resistance during Candida kefyr fungemia treatment with caspofungin. Antimicrob Agents Chemother. 2013;57: 2380–2382. pmid:23439642
- 31. Dannaoui E, Desnos-Ollivier M, Garcia-Hermoso D, Grenouillet F, Cassaing S, Baixench MT, et al. Candida spp. with acquired echinocandin resistance, France, 2004–2010. Emerg Infect Dis. 2012;18: 86–90. pmid:22257484
- 32. Baixench MT, Aoun N, Desnos-Ollivier M, Garcia-Hermoso D, Bretagne S, Ramires S, et al. Acquired resistance to echinocandins in Candida albicans: case report and review. J Antimicrob Chemother. 2007;59: 1076–1083. pmid:17468115
- 33. Pasquale T, Tomada JR, Ghannoun M, Dipersio J, Bonilla H. Emergence of Candida tropicalis resistant to caspofungin. J Antimicrob Chemother. 2008;61: 219.
- 34. Pfaller MA, Diekema DJ, Andes D, Arendrup MC, Brown SD, Lockhart SR, et al. Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug Resist Updat. 2011;14: 164–176. pmid:21353623
- 35. Pfaller MA, Diekema DJ, Ostrosky-Zeichner L, Rex JH, Alexander BD, Andes D, et al. Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints. J Clin Microbiol. 2008;46: 2620–2629. pmid:18579718
- 36. Gunde-Cimermana N, Zalarb P, de Hoogc S, Plemenitasd A. Hypersaline waters in salterns—natural ecological niches for halophilic black yeasts. FEMS Microbiol Ecol. 2000;32: 235–240. pmid:10858582
- 37. Kogej T, Stein M, Volkmann M, Gorbushina AA, Galinski EA, Gunde-Cimerman N. Osmotic adaptation of the halophilic fungus Hortaea werneckii: role of osmolytes and melanization. Microbiology. 2007;153: 4261–4273. pmid:18048939